Robert Lampert
Oral & Maxillofacial Surgery Newark, NJ Doctor of Dentistry
NPI 1629375415 CMS profile 1383429
110 Bergen St, Newark, NJ 07103
General payments
$1,497
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Robert Lampert of Newark, NJ is reported in the CMS Open Payments database as having received $1,497 across 9 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 60th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $41 | 1 | |
| 2024 | General | $74 | 1 | |
| 2021 | General | $50 | 1 | |
| 2019 | General | $1,332 | 6 |
Beside peers
- Robert Lampert
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Robert Lampert were reported at $41. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Robert Lampert | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,332 | $178 | $56–$584 | $163 |
| 2020 | $0 | $106 | $38–$316 | $114 |
| 2021 | $50 | $165 | $57–$511 | $132 |
| 2022 | $0 | $173 | $63–$494 | $149 |
| 2023 | $0 | $184 | $62–$521 | $160 |
| 2024 | $74 | $197 | $65–$603 | $164 |
| 2025 | $41 | $184 | $61–$541 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 6 drugsPart D claims
356
Drug cost
$1,456
Branded share of claims
16.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 109 | $476 | |
| Amoxicillin | Generic | 128 | $435 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 46 | $179 | |
| Ibuprofen | Generic | 36 | $163 | |
| Doxycycline Hyclate | Generic | 24 | $143 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 13 | $59 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$3,793
Medicare patients
12
Services billed
13
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| COPD | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
9 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in New Jersey
Shahid Aziz
Oral & Maxillofacial Surgery · Newark, NJ
Chang Min Yim
Oral & Maxillofacial Surgery · Newark, NJ
Rabie Shanti
Oral & Maxillofacial Surgery · Newark, NJ
Vincent Ziccardi
Oral & Maxillofacial Surgery · Newark, NJ
Manolis Manolakakis
Oral & Maxillofacial Surgery · Shrewsbury, NJ
Sung Hee Cho
Oral & Maxillofacial Surgery · River Edge, NJ
Related records
Oral & Maxillofacial Surgery in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.